Systemic EMD 68843 injections reduce anxiety in the shock-probe, but not the plus-maze test

Author： Treit D. Degroot A. kashluba S. Bartoszyk G.D.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.414, Iss.2, 2001-03, pp. : 245-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anxiogenic effect of sleep deprivation in the elevated plus-maze test in mice

By Silva Regina Kameda Sonia Carvalho Rita Takatsu-Coleman André Niigaki Suzy Abílio Vanessa Tufik Sergio Frussa-Filho Roberto

Psychopharmacology, Vol. 176, Iss. 2, 2004-11 ,pp. : 115-122

Springer Publishing Company

Access to resources Recommend Favorite

Evidence for an anxiogenic action of AMPA receptor antagonists in the plus-maze test

By Karcz-Kubicha M. Liljequist S.

European Journal of Pharmacology, Vol. 279, Iss. 2, 1995-06 ,pp. : 171-177

Elsevier

Access to resources Recommend Favorite

Anxiolytic effects of Stachys lavandulifolia Vahl on the elevated plus-maze model of anxiety in mice

By Rabbani M. Sajjadi S.E. Zarei H.R.

Journal of Ethnopharmacology, Vol. 89, Iss. 2, 2003-12 ,pp. : 271-276

Elsevier

Access to resources Recommend Favorite

Dopamine D 4 receptor and anxiety: Behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze

By Cao B.-J. Rodgers R.J.

European Journal of Pharmacology, Vol. 335, Iss. 2, 1997-09 ,pp. : 117-125

Elsevier

Access to resources Recommend Favorite

A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze

By Mechiel Korte S. De Boer S.F.

European Journal of Pharmacology, Vol. 463, Iss. 1, 2003-02 ,pp. : 163-175

Elsevier

Access to resources Recommend Favorite